Rescue Airway Devices Market Report 2026

The rescue airway devices market size has grown rapidly in recent years. It will grow from $2.76 billion in 2025 to $3.05 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to increasing mobile connectivity, rising sensor integration, expanding iot adoption, growing data analytics usage, and increasing indoor positioning demand.

The rescue airway devices market size is expected to see rapid growth in the next few years. It will grow to $4.49 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to growing context aware automation, rising real time localization needs, increasing smart infrastructure expansion, expanding ai enabled processing, and growing multi modal sensing adoption. Major trends in the forecast period include advancements in adaptive sensing, innovations in ambient automation, developments in multimodal fusion, research in predictive intelligence, and technology upgrades in spatial computing.

The increasing number of emergency cases is expected to drive the growth of the rescue airway devices market in the coming years. Emergency cases include acute medical situations such as road accidents, cardiac arrests, respiratory failure, and severe injuries that require immediate lifesaving interventions. The rise in emergency cases is fueled by growing road traffic accidents and violence-related injuries in increasingly urbanized and motorized populations, leading more people to seek urgent hospital care. Rescue airway devices assist in managing these emergencies by enabling rapid, reliable, and effective airway management in both pre-hospital and hospital settings, ensuring adequate oxygenation and reducing the risk of complications. For example, in October 2025, NHS England, a UK-based government health agency, reported approximately 401,800 emergency hospital admissions via all accident and emergency departments in September 2025 - averaging 13,400 per day - along with an additional 133,800 emergency admissions that did not come through accident and emergency departments, averaging 4,500 per day. Consequently, the rising number of emergency cases is boosting the demand for rescue airway devices.

The rising incidence of cardiac arrest cases is also expected to propel the growth of the rescue airway devices market. Cardiac arrest is a sudden loss of blood flow due to the heart’s inability to pump effectively, often caused by electrical malfunctions in the heart. The increasing incidence of cardiac arrest is driven by rising rates of heart disease, obesity, hypertension, and diabetes, which contribute to impaired heart function and abnormal heart rhythms. Rescue airway devices support cardiac arrest management by providing rapid airway control and effective oxygenation during emergency resuscitation, helping maintain uninterrupted ventilation until definitive care is delivered and improving survival outcomes. For instance, in February 2025, Hato Hone St John, a New Zealand-based ambulance service organization, reported that 2,547 people were treated for cardiac arrest in 2024, a 3.6% increase from 2023, with 72% of cases occurring at home. Therefore, the growing incidence of cardiac arrest cases is driving the expansion of the rescue airway devices market.

Major companies in the rescue airway devices market are focusing on developing advanced visual technologies, such as integrated video laryngoscopy solutions, to enhance clinician visibility, procedural accuracy, and patient safety during airway management in both routine and complex clinical situations. Integrated video laryngoscopy solutions are devices that combine high-resolution video imaging with ergonomic controls and software connectivity, allowing clinicians to visually guide intubation in real time and seamlessly share imaging data with hospital information systems. For example, in January 2025, Ambu A/S, a Denmark-based medical technology company, launched the Ambu SureSight Connect video laryngoscopy solution, designed to enable efficient endotracheal intubation in operating rooms and intensive care units. The solution integrates with Ambu’s digital platforms, including Ambu aView 2 Advance and Ambu aBox 2, streamlining workflow, reducing task complexity, and providing clinicians with comprehensive airway visualization tools. It is the only airway visualization system that features a one-lung ventilation solution and includes all devices recommended for airway assessment and intubation, expanding its utility across clinical settings.

Major companies operating in the rescue airway devices market are Medtronic plc, Medline Industries LP, GE HealthCare Technologies Inc., Becton, Dickinson and Company, Olympus Corporation, Smiths Group plc, Drägerwerk AG & Co. KGaA, Teleflex Incorporated, Cook Medical LLC, Nihon Kohden Corporation, Fisher & Paykel Healthcare Corporation Limited, Ambu A/S, Armstrong Medical Ltd., Vyaire Medical Inc., Vygon S.A., Intersurgical Ltd., Mercury Enterprises LLC, SunMed LLC, Verathon Inc., SourceMark LLC.

North America was the largest region in the rescue airway devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rescue airway devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the rescue airway devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the rescue airway devices market by increasing costs of imported medical-grade silicone, pvc materials, molding equipment, and sterilization components used in airway device manufacturing. hospitals and emergency services in north america and europe are most affected due to reliance on imported medical supplies, while asia-pacific faces cost pressure on device exports. these tariffs are raising procurement costs and affecting inventory planning. however, they are also driving local manufacturing, regional supplier development, and increased focus on cost-effective and disposable airway solutions.

Rescue airway devices are medical instruments designed to maintain or restore a patient’s airway during emergencies, such as respiratory distress or obstruction. Their main purpose is to ensure adequate ventilation and oxygenation, prevent airway collapse, and sustain life until definitive airway management can be provided.

The primary product types of rescue airway devices are supraglottic airway devices, laryngeal mask airways, intubating laryngeal mask airways, laryngeal tubes, i-gel airway devices, and other supraglottic devices. Supraglottic airway devices are emergency airway management tools designed to maintain airway patency without tracheal intubation during resuscitation and acute care scenarios. These devices are manufactured using materials such as silicone, polyvinyl chloride, thermoplastic elastomers, and others, and are designed for anatomical placement including simple adjuncts, supraglottic or extraglottic airway devices, infraglottic or tracheal devices, airway access or visualization tools, and ventilation or resuscitation devices, among end users such as hospitals, ambulatory surgery centers, clinics, emergency medical services providers, military and government medical units, and others.

The rescue airway devices market consists of sales of endotracheal tubes, laryngeal mask airways (LMAs), oropharyngeal and nasopharyngeal airways, supraglottic airway devices, and tracheostomy kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.